334 related articles for article (PubMed ID: 31100495)
21. Interleukin-6 inhibits growth hormone-mediated gene expression in hepatocytes.
Ahmed TA; Buzzelli MD; Lang CH; Capen JB; Shumate ML; Navaratnarajah M; Nagarajan M; Cooney RN
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1793-803. PubMed ID: 17395896
[TBL] [Abstract][Full Text] [Related]
22. Growth Hormone Induces Colon DNA Damage Independent of IGF-1.
Chesnokova V; Zonis S; Barrett RJ; Gleeson JP; Melmed S
Endocrinology; 2019 Jun; 160(6):1439-1447. PubMed ID: 31002310
[TBL] [Abstract][Full Text] [Related]
23. Human metastatic melanoma cell lines express high levels of growth hormone receptor and respond to GH treatment.
Sustarsic EG; Junnila RK; Kopchick JJ
Biochem Biophys Res Commun; 2013 Nov; 441(1):144-50. PubMed ID: 24134847
[TBL] [Abstract][Full Text] [Related]
24. Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after Box1, resulting in isolated failure of STAT 5 signal transduction.
Milward A; Metherell L; Maamra M; Barahona MJ; Wilkinson IR; Camacho-Hübner C; Savage MO; Bidlingmaier M; Clark AJ; Ross RJ; Webb SM
J Clin Endocrinol Metab; 2004 Mar; 89(3):1259-66. PubMed ID: 15001620
[TBL] [Abstract][Full Text] [Related]
25. Growth hormone stimulates hepatic expression of bovine growth hormone receptor messenger ribonucleic acid through signal transducer and activator of transcription 5 activation of a major growth hormone receptor gene promoter.
Jiang H; Wang Y; Wu M; Gu Z; Frank SJ; Torres-Diaz R
Endocrinology; 2007 Jul; 148(7):3307-15. PubMed ID: 17412814
[TBL] [Abstract][Full Text] [Related]
26. Craniopharyngioma cell growth is promoted by growth hormone (GH) and is inhibited by tamoxifen: involvement of growth hormone receptor (GHR) and IGF-1 receptor (IGF-1R).
Li Q; You C; Liu L; Rao Z; Sima X; Zhou L; Xu J
J Clin Neurosci; 2013 Jan; 20(1):153-7. PubMed ID: 23117141
[TBL] [Abstract][Full Text] [Related]
27. Mode of growth hormone action in osteoblasts.
DiGirolamo DJ; Mukherjee A; Fulzele K; Gan Y; Cao X; Frank SJ; Clemens TL
J Biol Chem; 2007 Oct; 282(43):31666-74. PubMed ID: 17698843
[TBL] [Abstract][Full Text] [Related]
28. Evolution of the receptors for growth hormone, prolactin, erythropoietin and thrombopoietin in relation to the vertebrate tetraploidizations.
Ocampo Daza D; Larhammar D
Gen Comp Endocrinol; 2018 Feb; 257():143-160. PubMed ID: 28652136
[TBL] [Abstract][Full Text] [Related]
29. Antiapoptotic effects of erythropoietin in differentiated neuroblastoma SH-SY5Y cells require activation of both the STAT5 and AKT signaling pathways.
Um M; Lodish HF
J Biol Chem; 2006 Mar; 281(9):5648-56. PubMed ID: 16407271
[TBL] [Abstract][Full Text] [Related]
30. Signaling cross talk between growth hormone (GH) and insulin-like growth factor-I (IGF-I) in pancreatic islet β-cells.
Ma F; Wei Z; Shi C; Gan Y; Lu J; Frank SJ; Balducci J; Huang Y
Mol Endocrinol; 2011 Dec; 25(12):2119-33. PubMed ID: 22034225
[TBL] [Abstract][Full Text] [Related]
31. Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge.
Goffin V
Pharmacol Ther; 2017 Nov; 179():111-126. PubMed ID: 28549597
[TBL] [Abstract][Full Text] [Related]
32. Hwanggeumchal sorghum extract enhances BMP7 and GH signaling through the activation of Jak2/STAT5B in MC3T3‑E1 osteoblastic cells.
Joung YH; Lim EJ; Darvin P; Jang JW; Park KD; Lee HK; Kim HS; Cho BW; Park T; Chung S; Park JH; Yang YM
Mol Med Rep; 2013 Sep; 8(3):891-6. PubMed ID: 23877734
[TBL] [Abstract][Full Text] [Related]
33. Endocrine systems in juvenile anadromous and landlocked Atlantic salmon (Salmo salar): seasonal development and seawater acclimation.
Nilsen TO; Ebbesson LO; Kiilerich P; Björnsson BT; Madsen SS; McCormick SD; Stefansson SO
Gen Comp Endocrinol; 2008 Feb; 155(3):762-72. PubMed ID: 17904138
[TBL] [Abstract][Full Text] [Related]
34. Growth hormone (GH) status regulates GH receptor and GH binding protein mRNA in a tissue- and transcript-specific manner but has no effect on insulin-like growth factor-I receptor mRNA in the rat.
Butler AA; Funk B; Breier BH; LeRoith D; Roberts CT; Gluckman PD
Mol Cell Endocrinol; 1996 Feb; 116(2):181-9. PubMed ID: 8647318
[TBL] [Abstract][Full Text] [Related]
35. Growth hormone affects gene expression and proliferation in human prostate cancer cells.
Bidosee M; Karry R; Weiss-Messer E; Barkey RJ
Int J Androl; 2011 Apr; 34(2):124-37. PubMed ID: 20546049
[TBL] [Abstract][Full Text] [Related]
36. Growth hormone signaling in fibroblasts from newborn boys and prepubertal boys.
Ocaranza P; Morales F; Matamala Á; Gaete X; Román R; Lammoglia JJ; Cassorla F
Growth Horm IGF Res; 2016 Apr; 27():18-27. PubMed ID: 26843474
[TBL] [Abstract][Full Text] [Related]
37. Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice.
Wennbo H; Gebre-Medhin M; Gritli-Linde A; Ohlsson C; Isaksson OG; Törnell J
J Clin Invest; 1997 Dec; 100(11):2744-51. PubMed ID: 9389738
[TBL] [Abstract][Full Text] [Related]
38. Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness.
Kavarthapu R; Dufau ML
Front Endocrinol (Lausanne); 2022; 13():949396. PubMed ID: 36187116
[TBL] [Abstract][Full Text] [Related]
39. Alpha
Castillo LF; Rivero EM; Goffin V; Lüthy IA
Cell Signal; 2017 Jun; 34():76-85. PubMed ID: 28302567
[TBL] [Abstract][Full Text] [Related]
40. Prolactin Signaling Stimulates Invasion via Na(+)/H(+) Exchanger NHE1 in T47D Human Breast Cancer Cells.
Pedraz-Cuesta E; Fredsted J; Jensen HH; Bornebusch A; Nejsum LN; Kragelund BB; Pedersen SF
Mol Endocrinol; 2016 Jul; 30(7):693-708. PubMed ID: 27176613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
